Subscribe to our
May 8th is World Ovarian Cancer Day. It is the one day every year the world stops to focus on a disease that is far too often overlooked until it is too late. It is not a rare cancer, yet it is routinely missed, misdiagnosed, and caught in its final stages.
World Ovarian Cancer Day 2026 is more than just a date on a calendar. It is a vital reminder that symptoms do exist, risk factors can be identified, and early detection truly saves lives. In this guide, we will look at the signs that often get ignored, the women most at risk, and the strategies that work for prevention. We will also explain why Felix Hospital is fully equipped to provide care at every stage of this journey.
World Ovarian Cancer Day is observed every year on May 8th. It was established in 2013 by a coalition of ovarian cancer organisations from around the world united by a single mission: no woman should die from ovarian cancer because she did not know the symptoms.
The day exists because ovarian cancer has one of the lowest early-detection rates among all cancers. Over 70% of cases are diagnosed at Stage III or Stage IV when the cancer has already spread beyond the ovaries. At that stage, survival rates drop sharply. Caught at Stage I, the five-year survival rate is above 90%. That gap is the entire reason World Ovarian Cancer Day matters.
In India, ovarian cancer is the third most common cancer in women after breast and cervical cancer. Thousands of new cases are diagnosed every year and thousands more go undetected until it is much harder to treat.
This is a label that, unfortunately, is well-earned. Ovarian cancer does not announce itself loudly. There is no national screening program, and unlike breast cancer with mammograms or cervical cancer with Pap smears, there is no single, definitive early detection test.
What makes it particularly dangerous is that the early symptoms are incredibly easy to dismiss. Bloating, slight pelvic discomfort, feeling full quickly, or needing to urinate more often are all signs women often attribute to stress, diet, or age. By the time these symptoms feel "serious" enough to see a doctor, the cancer has often moved beyond the ovaries.
This is not a reason to panic, but it is a reason to be vigilant. You need to know your body and act when something feels persistently wrong.
The signs of ovarian cancer are real; they are just subtle. The most important word to remember is persistence. A bloated day here or there is normal. Bloating that lasts for weeks without a clear cause is a warning.
The core symptoms to watch for include:
Bloating: A persistent feeling of fullness or visible swelling in the abdomen that is new and not related to your diet.
Pelvic or Abdominal Pain: Constant pressure or discomfort in the lower belly that is not linked to your period.
Difficulty Eating: Feeling stuffed almost immediately after starting a meal, even if you have eaten very little.
Urgent Urination: A new, unexplained need to urinate more frequently or with more urgency.
Bowel Changes: Persistent constipation or other changes in bowel habits.
Fatigue: A level of tiredness that rest does not fix.
Unexplained Weight Changes: Particularly visible distension in the abdominal area.
Pain During Intercourse: Any new or worsening discomfort during sex.
Abnormal Bleeding: Irregular periods or any bleeding after menopause must be checked immediately.
If you experience four or more of these symptoms persistently for more than two to three weeks, please see a gynecologist. Do not wait for things to get worse. Call us at +91 9667064100
While any woman can develop this cancer, certain factors increase the likelihood. Knowing these helps you stay proactive.
Age: It is most common in women over 50, but it can and does affect younger women.
Family History: Having a mother, sister, or daughter with the disease triples your risk. A family history of breast cancer is also a significant link.
Genetic Mutations: Women with BRCA1 or BRCA2 gene mutations have a much higher lifetime risk. Genetic counseling is highly recommended if your family history is strong.
Endometriosis: This condition is linked to a higher risk of specific types of ovarian cancer.
Pregnancy History: Women who have never carried a pregnancy to term may face a slightly higher risk.
Hormone Replacement Therapy (HRT): Long-term use of estrogen-only HRT after menopause has been linked to increased risk.
Obesity: Excess weight, especially around the midsection, is linked to higher risk and poorer outcomes.
Ovarian cancer is staged from I to IV based on how far the cancer has spread at the time of diagnosis.
Stage | Description | Approximate 5-Year Survival Rate |
Stage I | Cancer confined to one or both ovaries | 85–93% |
Stage II | Cancer has spread to pelvic organs | 70–80% |
Stage III | Cancer has spread to the abdomen or lymph nodes | 30–55% |
Stage IV | Cancer has spread to distant organs (liver, lungs) | 15–25% |
The numbers make the case plainly. Stage I survival is above 85%. Stage IV survival is around 15–25%. The difference is detection and detection comes from knowing the symptoms and acting on them.
Over 75% of Indian women with ovarian cancer are diagnosed at Stage III or IV. That is not because the symptoms were not there, it is because they were not recognised or acted upon in time.
Not all ovarian cancers are the same. Understanding the type matters for treatment planning.
Epithelial ovarian cancer accounts for approximately 85–90% of all ovarian cancers. Begins in the cells on the outer surface of the ovary. Includes serous, mucinous, endometrioid, and clear cell subtypes.
Germ cell tumours arise from the egg-producing cells. More common in younger women and girls. Generally more treatable than epithelial cancers.
Sex cord-stromal tumours develop from the structural cells of the ovary. Often produce hormones and may cause abnormal bleeding. Less common but often caught earlier because of hormonal symptoms.
Borderline ovarian tumours Also called low malignant potential tumours. Less aggressive than invasive cancers and generally associated with better outcomes.
Treatment surgery, chemotherapy, targeted therapy is planned based on the specific type, stage, and grade of the tumour.
Since there is no "standard" screening, doctors use a combination of tools to find the truth:
Pelvic Exam: A physical check for masses or abnormalities.
Transvaginal Ultrasound (TVUS): Usually the first imaging step to look closely at the ovaries.
CA-125 Blood Test: This measures a protein often elevated in cancer cases. While not definitive on its own, it provides a crucial piece of the puzzle.
CT or MRI: These scans show the size and location of any suspected tumors.
Biopsy: This is the only way to confirm cancer, usually done during surgery.
At Felix Hospital, we provide all these diagnostic services on-site, ensuring you get answers without being referred elsewhere.
There is no absolute way to prevent it, but you can lower your risk:
Oral Contraceptives: Using birth control pills for five or more years can reduce risk by 30–50%.
Breastfeeding: Each full-term pregnancy and period of breastfeeding offers some protective benefit.
Surgical Options: For those at very high genetic risk, removing the fallopian tubes and ovaries can be a life-saving preventive measure.
Healthy Lifestyle: Maintaining a healthy weight and staying active reduces overall cancer risk.
Know Your History: If your family has a history of breast or ovarian cancer, get tested for the BRCA gene.
Our oncology department manages ovarian cancer with a comprehensive, patient-first approach:
Advanced Surgery: We specialize in cytoreductive surgery (debulking) to remove as much of the tumor as possible, which is the foundation of successful treatment.
Medical Oncology: We provide post-surgical chemotherapy and targeted therapies like PARP inhibitors in a dedicated, supportive environment.
Genetic Testing: On-site services help us characterize tumors accurately to choose the right medicine.
Holistic Support: From nutritional guidance to psychological counseling and palliative care, we support the patient and the family through the entire process.
Check your symptoms: If you’ve been bloated or in pain for three weeks, book an appointment today.
Check your history: If cancer runs in your family, ask your doctor about genetic testing.
Spread the word: Tell your mother, your sister, and your friends. Most women diagnosed with this disease wish they had known the symptoms earlier.
Ovarian cancer does not have to be a death sentence. The danger lies in catching it too late. World Ovarian Cancer Day 2026 is your reminder to pay attention to your body. If something feels wrong, it probably is. Persistent bloating and pain are not things to "just live with."
The oncology and gynecology teams at Felix Hospital are here to help you with diagnosis, second opinions, and state-of-the-art treatment.
Call us at +91 9667064100 Gynaecological Oncology Helpdesk, Felix Hospital, Gamma-1, Greater Noida
Ovarian cancer has a hereditary component in approximately 15–20% of cases. The most significant hereditary risk factors are BRCA1 and BRCA2 gene mutations and Lynch syndrome. If two or more close relatives particularly a mother, sister, or daughter have had ovarian or breast cancer, genetic counselling and BRCA testing is strongly recommended.
Early detection is possible but challenging because there is currently no routine national screening test for ovarian cancer in the general population. Transvaginal ultrasound and CA-125 blood testing are used in women with symptoms or elevated risk, but neither is used as a mass screening tool. The best route to early detection is knowing the symptoms and acting quickly when they appear persistently.
Survival rates depend heavily on the stage at diagnosis. Stage I ovarian cancer has a five-year survival rate above 85%. Stage III and IV where most Indian women are diagnosed have survival rates ranging from 15% to 55%. Improving survival in India requires earlier diagnosis, which requires awareness of symptoms at the community level.
Yes. While ovarian cancer is most common in women over 50, it occurs in younger women as well. Germ cell tumours, in particular, are more common in younger women and girls. No age group is entirely excluded. Any woman with persistent unexplained symptoms should seek evaluation regardless of age.
CA-125 is a blood test that measures the level of a protein often elevated in ovarian cancer. However, it is not a screening test for the general population because elevated CA-125 can occur in many benign conditions including endometriosis, fibroids, pelvic inflammatory disease, and even pregnancy. It is most useful when combined with imaging in women who already have symptoms or elevated risk.
Yes. Both PM-JAY (Ayushman Bharat) and CGHS cover cancer diagnosis and treatment including surgery, chemotherapy, and radiation therapy under approved package rates. Felix Hospital is empanelled under both schemes. Eligible beneficiaries can receive cashless ovarian cancer treatment at Felix Hospital. Call +91 9667064100 to confirm coverage for your specific treatment plan.